Expandable Absorbable Breast Implants for Reconstruction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for breast reconstruction following mastectomy, such as using acellular dermal matrices, are limited by resistance to stretching, high cost, and risks of disease transmission, and existing absorbable implants do not expand with tissue expanders, leading to patient discomfort and increased surgical complexity.

Innovation Solution

Development of absorbable and expandable implants made from poly-4-hydroxybutyrate (P4HB) polymers with sacrificial and non-sacrificial elements that allow for uniaxial and biaxial expansion, reducing stress on the pectoralis major muscle and enabling tissue ingrowth, which are completely absorbed in vivo, eliminating the need for additional surgical steps and reducing postoperative pain.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If acellular dermal matrix (ADM) is used to cover the tissue expander, then the need to release and elevate multiple muscles is eliminated and postoperative pain is reduced, but the ADM resists stretching which puts undue stress on the pectoralis major muscle and can be uncomfortable for the patient

Engineering Contradiction:
Improvesurgical procedure simplicityVSAvoidstretching resistance
Core Design Contradiction:
Ease of operationVSStrength

Solution Approach 1:

The implant is divided into two functional components: a non-absorbable mesh scaffold that provides structural support and stretching resistance, and an absorbable gelatinous material that provides compliance and allows expansion. This segmentation resolves the contradiction by assigning different mechanical properties to different parts of the same implant system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The implant combines two dissimilar materials with complementary properties: a synthetic mesh (providing strength and stretch resistance) and absorbable gelatin (providing compliance and biocompatibility). This composite structure allows the implant to both resist excessive stretching and accommodate necessary expansion during tissue growth.

Inventive Principle:
Principle #40Composite materials

2Volume of moving object

If acellular dermal matrix (ADM) is used, then creation of a larger pocket size and more rapid expansion is enabled, but the ADM is very expensive

Engineering Contradiction:
Improvepocket sizeVSAvoidcost
Core Design Contradiction:
Volume of moving objectVSEase of manufacture

Solution Approach 1:

The implant uses absorbable gelatin that degrades over time (short-living), allowing the pocket to expand and be replaced with permanent implant tissue. This absorbable component is replaced by a permanent implant afterward, making the expensive ADM function temporarily and affordably.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If acellular dermal matrix (ADM) is used, then reduced incidence of capsular contracture formation and improvements in aesthetic results are achieved, but ADM is an animal or human derived implant with an associated risk of disease transmission

Engineering Contradiction:
Improvecapsular contracture resistanceVSAvoiddisease transmission risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The absorbable gelatin component serves as a temporary barrier during the critical healing period (reducing capsular contracture), then degrades and is absorbed by the body. Since it's temporary and fully absorbed, disease transmission risk is minimized while maintaining the protective benefits during the vulnerable early period.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The implant's mechanical properties change over time as the absorbable gelatin degrades. Initially, it provides compliance and protection similar to ADM; as it degrades, the permanent implant tissue takes over the protective function. This temporal parameter change allows ADM-like benefits without long-term presence of animal-derived materials.

Inventive Principle:
Principle #35Parameter changes

4Duration of action of stationary object

If existing absorbable implants are used, then complete absorption in vivo is achieved, but they do not expand with tissue expanders leading to patient discomfort and increased surgical complexity

Engineering Contradiction:
Improveabsorption timeVSAvoidexpandability
Core Design Contradiction:
Duration of action of stationary objectVSAdaptability or versatility

Solution Approach 1:

The implant is segmented into an expandable mesh scaffold and an absorbable gelatinous filler. The mesh provides the expandable structure that moves with tissue expansion, while the gelatin provides the absorbable component. This segmentation allows both expandability and complete absorption to coexist.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The implant is designed to be dynamic rather than static. The mesh scaffold dynamically expands with tissue growth during the expansion phase, then the gelatinous material dynamically degrades and is absorbed over time. This dynamic behavior allows the implant to adapt to both expansion and absorption requirements.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20230165673A1Expandable absorbable implants for breast reconstruction and augmentation
Publication Date: 2023.06.01 TEPHA INC
  • US20230165673A1 patent drawing
  • US20230165673A1 patent drawing
  • US20230165673A1 patent drawing

AI summary

Expandable absorbable implants have been developed that are suitable for breast reconstruction following mastectomy. The implants can be implanted in the vicinity of a tissue expander, for example, by suturing to the detached edge of the pectoralis major muscle to function as a pectoralis extender, and used to form a sling for a tissue expander. The implants, which permit tissue-ingrowth and slowly degrade, can be expanded in the breast using a tissue expander in order to form a pocket for a permanent breast implant. After expansion, the tissue expander can be removed and replaced with a permanent breast implant. The expandable implants help reduce patient discomfort resulting from tissue expansion, and avoid the need to use allografts or xenografts to create the pocket for the tissue expander. The expandable absorbable implant preferably comprises poly-4-hydroxybutyrate or copolymer thereof.